Evofem Biosciences Stock Total Asset
Evofem Biosciences fundamentals help investors to digest information that contributes to Evofem Biosciences' financial success or failures. It also enables traders to predict the movement of Evofem OTC Stock. The fundamental analysis module provides a way to measure Evofem Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Evofem Biosciences otc stock.
Evofem |
Evofem Biosciences OTC Stock Total Asset Analysis
Evofem Biosciences' Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Evofem Biosciences Total Asset | 42.51 M |
Most of Evofem Biosciences' fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Evofem Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
CompetitionBased on the latest financial disclosure, Evofem Biosciences has a Total Asset of 42.51 M. This is 99.43% lower than that of the Pharmaceuticals sector and 97.85% lower than that of the Health Care industry. The total asset for all United States stocks is 99.86% higher than that of the company.
Evofem Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Evofem Biosciences' direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Evofem Biosciences could also be used in its relative valuation, which is a method of valuing Evofem Biosciences by comparing valuation metrics of similar companies.Evofem Biosciences is currently under evaluation in total asset category among its peers.
Evofem Fundamentals
Return On Equity | -3.87 | ||||
Return On Asset | -1.25 | ||||
Operating Margin | (5.41) % | ||||
Current Valuation | 112.69 M | ||||
Shares Outstanding | 121.22 M | ||||
Shares Owned By Insiders | 0.28 % | ||||
Shares Owned By Institutions | 0.57 % | ||||
Number Of Shares Shorted | 8.68 M | ||||
Price To Earning | (1.26) X | ||||
Price To Book | 8.37 X | ||||
Price To Sales | 0.42 X | ||||
Revenue | 8.24 M | ||||
Gross Profit | 4.19 M | ||||
EBITDA | (204.14 M) | ||||
Net Income | (205.19 M) | ||||
Cash And Equivalents | 19.89 M | ||||
Cash Per Share | 0.23 X | ||||
Total Debt | 125.74 M | ||||
Debt To Equity | 8.72 % | ||||
Current Ratio | 0.16 X | ||||
Book Value Per Share | (0.77) X | ||||
Cash Flow From Operations | (146.67 M) | ||||
Short Ratio | 0.19 X | ||||
Earnings Per Share | (19.01) X | ||||
Target Price | 2.9 | ||||
Number Of Employees | 119 | ||||
Beta | -1.25 | ||||
Market Capitalization | 6.41 M | ||||
Total Asset | 42.51 M | ||||
Retained Earnings | (526.68 M) | ||||
Working Capital | 3.78 M | ||||
Current Asset | 16.39 M | ||||
Current Liabilities | 12.61 M | ||||
Z Score | -30.0 | ||||
Net Asset | 42.51 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in census. Note that the Evofem Biosciences information on this page should be used as a complementary analysis to other Evofem Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Evofem OTC Stock
If you are still planning to invest in Evofem Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Evofem Biosciences' history and understand the potential risks before investing.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |